Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS)
CNY 9.33
(0.0%)
CNY 9.33
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -38.27 Million CNY | 47.72% |
| 2022 | -73.2 Million CNY | -123.32% |
| 2021 | -32.78 Million CNY | 36.41% |
| 2020 | -51.54 Million CNY | -201.71% |
| 2019 | 50.68 Million CNY | 613.15% |
| 2018 | -9.87 Million CNY | -237.57% |
| 2017 | 7.17 Million CNY | 489.81% |
| 2016 | 1.21 Million CNY | 105.65% |
| 2015 | -21.54 Million CNY | -893.97% |
| 2014 | 2.71 Million CNY | 28.69% |
| 2013 | 2.1 Million CNY | 102.3% |
| 2012 | -91.59 Million CNY | -446.43% |
| 2011 | 26.43 Million CNY | 399.44% |
| 2010 | -8.82 Million CNY | 83.1% |
| 2009 | -52.24 Million CNY | -1380.63% |
| 2008 | 4.07 Million CNY | -73.02% |
| 2007 | 15.12 Million CNY | 3813.0% |
| 2006 | 386.43 Thousand CNY | -89.47% |
| 2005 | 3.67 Million CNY | -46.82% |
| 2004 | 6.9 Million CNY | 159.18% |
| 2003 | -11.66 Million CNY | -695.61% |
| 2002 | 1.95 Million CNY | -41.85% |
| 2001 | 3.36 Million CNY | 35.54% |
| 2000 | 2.48 Million CNY | -82.07% |
| 1999 | 13.86 Million CNY | -38.64% |
| 1998 | 22.58 Million CNY | 7.04% |
| 1997 | 21.1 Million CNY | 1.28% |
| 1996 | 20.83 Million CNY | 54.96% |
| 1995 | 13.44 Million CNY | -13.13% |
| 1994 | 15.47 Million CNY | 55.42% |
| 1993 | 9.95 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -9.72 Million CNY | 10.12% |
| 2024 Q3 | 14.8 Million CNY | 268.66% |
| 2024 Q2 | -8.77 Million CNY | 9.72% |
| 2023 Q2 | -14.36 Million CNY | -56.95% |
| 2023 Q1 | -9.15 Million CNY | 76.37% |
| 2023 FY | -38.27 Million CNY | 47.72% |
| 2023 Q3 | -4.03 Million CNY | 71.9% |
| 2023 Q4 | -10.81 Million CNY | -167.95% |
| 2022 Q3 | -7.35 Million CNY | 51.3% |
| 2022 Q1 | -3.19 Million CNY | 78.19% |
| 2022 FY | -73.2 Million CNY | -123.32% |
| 2022 Q4 | -38.73 Million CNY | -426.82% |
| 2022 Q2 | -15.09 Million CNY | -371.86% |
| 2021 FY | -32.78 Million CNY | 36.41% |
| 2021 Q1 | -3.06 Million CNY | 91.57% |
| 2021 Q2 | -3.08 Million CNY | -0.4% |
| 2021 Q3 | -8.97 Million CNY | -191.41% |
| 2021 Q4 | -14.67 Million CNY | -63.39% |
| 2020 FY | -51.54 Million CNY | -201.71% |
| 2020 Q1 | -24.69 Thousand CNY | -100.05% |
| 2020 Q2 | -2.37 Million CNY | -9521.57% |
| 2020 Q3 | -1.71 Million CNY | 27.82% |
| 2020 Q4 | -36.4 Million CNY | -2022.6% |
| 2019 Q3 | -1.35 Million CNY | -134.07% |
| 2019 Q1 | -1.87 Million CNY | 88.77% |
| 2019 Q2 | 3.98 Million CNY | 312.78% |
| 2019 Q4 | 52.92 Million CNY | 3993.73% |
| 2019 FY | 50.68 Million CNY | 613.15% |
| 2018 Q1 | -1.88 Million CNY | -208.7% |
| 2018 Q2 | 11.76 Million CNY | 724.78% |
| 2018 Q3 | -2.3 Million CNY | -119.61% |
| 2018 Q4 | -16.7 Million CNY | -623.99% |
| 2018 FY | -9.87 Million CNY | -237.57% |
| 2017 Q4 | -609.9 Thousand CNY | -103.87% |
| 2017 Q2 | -4.13 Million CNY | -33.64% |
| 2017 Q1 | -3.09 Million CNY | -282.79% |
| 2017 FY | 7.17 Million CNY | 489.81% |
| 2017 Q3 | 15.76 Million CNY | 481.35% |
| 2016 FY | 1.21 Million CNY | 105.65% |
| 2016 Q3 | 7.77 Million CNY | 335.13% |
| 2016 Q2 | -3.3 Million CNY | 33.11% |
| 2016 Q1 | -4.94 Million CNY | 45.11% |
| 2016 Q4 | 1.69 Million CNY | -78.24% |
| 2015 Q1 | -3.38 Million CNY | -755.9% |
| 2015 FY | -21.54 Million CNY | -893.97% |
| 2015 Q4 | -9 Million CNY | -29.55% |
| 2015 Q3 | -6.95 Million CNY | -216.44% |
| 2015 Q2 | -2.19 Million CNY | 35.06% |
| 2014 Q4 | 515.87 Thousand CNY | -81.76% |
| 2014 FY | 2.71 Million CNY | 28.69% |
| 2014 Q1 | 1.16 Million CNY | -76.57% |
| 2014 Q2 | -1.79 Million CNY | -254.38% |
| 2014 Q3 | 2.82 Million CNY | 257.81% |
| 2013 FY | 2.1 Million CNY | 102.3% |
| 2013 Q2 | -1.81 Million CNY | -165.06% |
| 2013 Q4 | 4.95 Million CNY | 229.67% |
| 2013 Q3 | -3.82 Million CNY | -110.65% |
| 2013 Q1 | 2.78 Million CNY | 104.52% |
| 2012 FY | -91.59 Million CNY | -446.43% |
| 2012 Q4 | -61.64 Million CNY | -1387.39% |
| 2012 Q2 | -18.68 Million CNY | -162.46% |
| 2012 Q3 | -4.14 Million CNY | 77.81% |
| 2012 Q1 | -7.11 Million CNY | -127.62% |
| 2011 Q4 | 25.77 Million CNY | 8352.87% |
| 2011 Q1 | 930.81 Thousand CNY | 112.55% |
| 2011 Q3 | 304.9 Thousand CNY | 153.54% |
| 2011 Q2 | -569.46 Thousand CNY | -161.18% |
| 2011 FY | 26.43 Million CNY | 399.44% |
| 2010 Q1 | 144.28 Thousand CNY | 100.88% |
| 2010 Q2 | 491.99 Thousand CNY | 240.99% |
| 2010 Q3 | -2.04 Million CNY | -516.53% |
| 2010 Q4 | -7.41 Million CNY | -261.9% |
| 2010 FY | -8.82 Million CNY | 83.1% |
| 2009 Q2 | -25.8 Million CNY | -5225.87% |
| 2009 Q3 | -10.56 Million CNY | 59.03% |
| 2009 Q1 | 503.33 Thousand CNY | 126.09% |
| 2009 FY | -52.24 Million CNY | -1380.63% |
| 2009 Q4 | -16.37 Million CNY | -54.94% |
| 2008 Q1 | 4.89 Million CNY | -35.47% |
| 2008 Q4 | -1.92 Million CNY | -333.82% |
| 2008 Q3 | -444.66 Thousand CNY | -128.51% |
| 2008 FY | 4.07 Million CNY | -73.02% |
| 2008 Q2 | 1.55 Million CNY | -68.13% |
| 2007 Q2 | 3.51 Million CNY | 93.72% |
| 2007 Q4 | 7.58 Million CNY | 243.86% |
| 2007 Q3 | 2.2 Million CNY | -37.28% |
| 2007 Q1 | 1.81 Million CNY | 222.86% |
| 2007 FY | 15.12 Million CNY | 3813.0% |
| 2006 Q1 | 1.2 Million CNY | 66.84% |
| 2006 FY | 386.43 Thousand CNY | -89.47% |
| 2006 Q4 | -1.47 Million CNY | -453.93% |
| 2006 Q3 | 417.43 Thousand CNY | 75.66% |
| 2006 Q2 | 237.63 Thousand CNY | -80.34% |
| 2005 Q3 | 6509.64 CNY | -99.64% |
| 2005 Q1 | 1.15 Million CNY | -74.58% |
| 2005 FY | 3.67 Million CNY | -46.82% |
| 2005 Q2 | 1.78 Million CNY | 55.64% |
| 2005 Q4 | 724.52 Thousand CNY | 11029.99% |
| 2004 FY | 6.9 Million CNY | 159.18% |
| 2004 Q4 | 4.52 Million CNY | 3556.78% |
| 2004 Q1 | 1.27 Million CNY | 109.34% |
| 2004 Q2 | 1.23 Million CNY | -3.16% |
| 2004 Q3 | -130.88 Thousand CNY | -110.6% |
| 2003 Q2 | 1.41 Million CNY | 30.35% |
| 2003 FY | -11.66 Million CNY | -695.61% |
| 2003 Q4 | -13.65 Million CNY | -2572.37% |
| 2003 Q1 | 1.08 Million CNY | 221.87% |
| 2003 Q3 | -511.04 Thousand CNY | -136.09% |
| 2002 Q3 | 655.22 Thousand CNY | -43.92% |
| 2002 Q4 | -891.48 Thousand CNY | -236.06% |
| 2002 Q1 | 1.02 Million CNY | -27.12% |
| 2002 FY | 1.95 Million CNY | -41.85% |
| 2002 Q2 | 1.16 Million CNY | 13.82% |
| 2001 FY | 3.36 Million CNY | 35.54% |
| 2001 Q4 | 1.4 Million CNY | 2085.76% |
| 2001 Q3 | -70.92 Thousand CNY | 0.0% |
| 2000 FY | 2.48 Million CNY | -82.07% |
| 1999 FY | 13.86 Million CNY | -38.64% |
| 1998 FY | 22.58 Million CNY | 7.04% |
| 1997 FY | 21.1 Million CNY | 1.28% |
| 1996 FY | 20.83 Million CNY | 54.96% |
| 1995 FY | 13.44 Million CNY | -13.13% |
| 1994 FY | 15.47 Million CNY | 55.42% |
| 1993 FY | 9.95 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 4.3 Billion CNY | 100.89% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 2.79 Billion CNY | 101.368% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 591.57 Million CNY | 106.47% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 57 Million CNY | 167.149% |
| Aurora Optoelectronics Co.,Ltd. | -675.27 Million CNY | 94.332% |
| NanJing Pharmaceutical Company Limited | 577.82 Million CNY | 106.624% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 90.07 Million CNY | 142.491% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.16 Billion CNY | 103.277% |